comparemela.com

Latest Breaking News On - ப்ரைவேட் பத்திரங்கள் சீர்திருத்தம் நாடகம் - Page 3 : comparemela.com

Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

Ardelyx Announces Extension of the PDUFA Review Period for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

China
Japan
Canada
Mike-raab
Fosun-pharma
Exchange-commission
Exchange-commission-on
Drug-administration
Ardelyx-inc
Nasdaq
Prescription-drug-user-fee-act
New-drug-application

Williams to Report First-Quarter 2021 Financial Results on May 3; Earnings Conference Call and Webcast Scheduled for May 4

Press release content from Business Wire. The AP news staff was not involved in its creation. Williams to Report First-Quarter 2021 Financial Results on May 3; Earnings Conference Call and Webcast Scheduled for May 4 April 12, 2021 GMT TULSA, Okla. (BUSINESS WIRE) Apr 12, 2021 Williams (NYSE: WMB) plans to announce its first-quarter 2021 financial results after the market closes on Monday, May 3, 2021. The company’s first-quarter 2021 earnings conference call and webcast with analysts and investors is scheduled for Tuesday, May 4, 2021, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). Participants who wish to join the call by phone must register using the following link: http://www.directeventreg.com/registration/event/5942459

Tulsa
Oklahoma
United-states
Danilo-juvane
Exchange-commission
Private-securities-reform-act
Business-wire
Business
Corporate-news
North-america
Earnings-conference-calls
Energy-industry

Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights Company well positioned for PDUFA date of April 29, 2021 and the potential launch of tenapanor News provided by Share this article Share this article FREMONT, Calif. and WALTHAM, Mass., March 8, 2021 /PRNewswire/  Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2020. The stage is set for an exciting year for Ardelyx in 2021 said Mike Raab, president and chief executive officer at Ardelyx. With our PDUFA date of April 29 rapidly approaching, we are well positioned and well prepared to commercialize tenapanor upon potential FDA approval of the first and only phosphate absorption inhibitor for the control of serum phosphorus. In addition,

China
El-paso
Texas
United-states
Japan
Canada
Mike-raab
Jennifer-robinson
Justin-renz
Laura-williams
Douglas-paul
Susan-rodriguez

Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

China
El-paso
Texas
United-states
Japan
Canada
Mike-raab
Jennifer-robinson
Justin-renz
Laura-williams
Douglas-paul
Susan-rodriguez
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.